Selecky Christobel's Form 4 filing
ImmunityBio, Inc. (IBRX) · filed Jan 21, 2026
- Accession no.
- 0001849739-26-000002
- Filed
- Jan 21, 2026
- Trade date
- Jan 16-20, 2026
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $437.8K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Selecky ChristobelCIK 0001849739 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 16, 2026 | Common Stock | MOption exerciseAcquired | +50,000 | $2.98 | +$149,000 | 50,000 | Direct | |
| Jan 16, 2026 | Common Stock | SSaleDisposed | −50,000 | $5.00 | −$250,000 | 0 | Direct | |
| Jan 20, 2026 | Common Stock | MOption exerciseAcquired | +25,000 | $2.98 | +$74,500 | 25,000 | Direct | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −25,000 | $7.51F2 | −$187,750 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 16, 2026 | Common Stock | MOption exerciseDisposed | −50,000 | $0.00 | $0 | 117,937 | Direct | |
| Jan 20, 2026 | Common Stock | MOption exerciseDisposed | −25,000 | $0.00 | $0 | 92,937 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average share price of an aggregate total of 25,000 shares sold in the price range of $7.50 to $7.52 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
Remarks
Exhibit 24 - Power of Attorney